A randomized clinical trial to evaluate the single-dose pharmacokinetics, pharmacodynamics, and safety of sitagliptin in pediatric patients with type 2 diabetes

导出原文传递

翻译打印收藏纠错

作者： Fraser, Iain P. ^[1] ; Neufeld, Naomi D. ^[2] ; Fox, Larry A. ^[3] ; Kipnes, Mark S. ^[4] ; Miller, Tracie L. ^[5] ; Zeitler, Philip S. ^[6] ; Rodriguez, Henry ^[7] ; Gilmartin, Jocelyn H. ; Lee, Susan J. ; Patterson, Jaclyn K. ; Li, Xiujiang S. ; Maganti, Lata ; Luo, Wen-Lin ; Tatosian, Daniel A. ; Stoch, S. Aubrey

作者单位： Univ Colorado, Sch Med, Childrens Hosp Colorado, Pediat Endocrinol, Aurora, CO USA ^[1] James Whitcomb Riley Hosp Children, Pediat Diabet Clin Program, 702 Barnhill Dr K-21, Indianapolis ^[2] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA ^[3] Diabet & Glandular Dis Clin, San Antonio, TX USA ^[4] Merck & Co Inc, Dept Clin Res, Kenilworth, NJ USA ^[5] Nemours Childrens Hlth Syst, Dept Endocrinol & Diabet, Jacksonville, FL USA ^[6] Neufeld Med Grp, West Hollywood, CA USA ^[7]

关键词 antihyperglycemic agents dipeptidyl peptidase-IV inhibitor DPP-4 incretin MK-0431

发布时间 2019-05-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交